McKesson Stock Price, News & Analysis (NYSE:MCK)

$150.50 +1.80 (+1.21 %)
(As of 02/16/2018 04:00 PM ET)
Previous Close$150.50
Today's Range$148.06 - $152.04
52-Week Range$133.82 - $178.86
Volume1.71 million shs
Average Volume1.92 million shs
Market Capitalization$31.38 billion
P/E Ratio7.24
Dividend Yield0.90%

About McKesson (NYSE:MCK)

McKesson logoMcKesson Corporation is a healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology company. The Company provides medicines, medical products and healthcare services by partnering with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare. It operates through two segments: McKesson Distribution Solutions and McKesson Technology Solutions. The distribution solutions segment distributes branded and generic pharmaceutical drugs and other healthcare-related products internationally and provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. Technology Solutions segment provides software and analytics, network solutions and technology-enabled services.

Receive MCK News and Ratings via Email

Sign-up to receive the latest news and ratings for MCK and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Drug Retailers
Sub-IndustryHealth Care Distributors
SectorNon-Cyclical Consumer Goods & Services


Debt-to-Equity Ratio0.63%
Current Ratio1.07%
Quick Ratio0.61%


Trailing P/E Ratio7.23557692307692
Forward P/E Ratio11.84
P/E Growth1.35

Sales & Book Value

Annual Sales$198.53 billion
Price / Sales0.16
Cash Flow$18.15 per share
Price / Cash8.29
Book Value$58.02 per share
Price / Book2.59


Trailing EPS$20.80
Net Income$5.07 billion
Net Margins2.34%
Return on Equity22.98%
Return on Assets4.22%


Outstanding Shares206,340,000

McKesson (NYSE:MCK) Frequently Asked Questions

What is McKesson's stock symbol?

McKesson trades on the New York Stock Exchange (NYSE) under the ticker symbol "MCK."

How often does McKesson pay dividends? What is the dividend yield for McKesson?

McKesson announced a quarterly dividend on Thursday, February 1st. Investors of record on Thursday, March 1st will be paid a dividend of $0.34 per share on Monday, April 2nd. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.90%. The ex-dividend date is Wednesday, February 28th. View McKesson's Dividend History.

How will McKesson's stock buyback program work?

McKesson declared that its board has authorized a stock buyback program on Thursday, October 27th 2016, which allows the company to repurchase $4,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization allows the company to buy up to 114% of its shares through open market purchases. Shares repurchase programs are typically an indication that the company's board of directors believes its stock is undervalued.

How were McKesson's earnings last quarter?

McKesson Co. (NYSE:MCK) issued its quarterly earnings data on Thursday, February, 1st. The company reported $3.41 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $2.92 by $0.49. The firm had revenue of $53.62 billion for the quarter, compared to the consensus estimate of $51.98 billion. McKesson had a net margin of 2.34% and a return on equity of 22.98%. The company's quarterly revenue was up 7.0% on a year-over-year basis. During the same period last year, the business posted $3.04 EPS. View McKesson's Earnings History.

When will McKesson make its next earnings announcement?

McKesson is scheduled to release their next quarterly earnings announcement on Thursday, May, 17th 2018. View Earnings Estimates for McKesson.

What guidance has McKesson issued on next quarter's earnings?

McKesson updated its FY18 earnings guidance on Thursday, February, 1st. The company provided earnings per share (EPS) guidance of $12.50-12.80 for the period, compared to the Thomson Reuters consensus EPS estimate of $12.26.

Where is McKesson's stock going? Where will McKesson's stock price be in 2018?

14 Wall Street analysts have issued 12 month price objectives for McKesson's stock. Their forecasts range from $130.00 to $205.00. On average, they anticipate McKesson's share price to reach $178.57 in the next year. View Analyst Ratings for McKesson.

What are Wall Street analysts saying about McKesson stock?

Here are some recent quotes from research analysts about McKesson stock:

  • 1. According to Zacks Investment Research, "Over the last year, McKesson has had an unfavorable run on the bourses. However, we are upbeat about the recent acquisition of RxCrossroads which should strengthen the company’s foothold in pharmaceutical and biotechnology space, apart from its balanced segmental and geographic show. Among other buyouts, the purchase of retailer is expected to bring online commerce capabilities and digital experience to McKesson Canada's retail assets. The company’s strong guidance for fiscal 2018 also holds promise. On the flip side, stiff competition, currency headwind, reimbursement issues continue to pose challenges. Pricing pressure in the independent retail pharmacy channel is a headwind. Particularly, McKesson’s sell-side pricing environment continues to remain competitive with less pricing variability." (2/15/2018)
  • 2. Citigroup Inc analysts commented, "MCK yesterday announced the completion of its previously-announced agreement w/Change Healthcare (CHC) to create a new HCIT company retaining the same name, combining substantially all of CHC's business and the majority of MCK Tech. Solutions, less its EIS segment which will remain in MTS. Initial plans to merge assets were announced on 6/28/16. Mgmt provided color on the NewCo's financial implications, largely consistent with expectations, with recognition occurring on a 1-month lag (reducing guided F4Q17 adj EPS by ~$0.15). We update our estimates to fully reflect today's guidance on the NewCo, but currently assume a full FY18 RAD contribution to MCK. Net, we maintain our Buy, as headwinds appear to be stabilizing while the WMT contract should improve purchasing power, with some offsets given initial Change dilution and a likely F2H18 loss of RAD; $175 TP (+$6), ~13-14x CY17 EPS, ~17% ETR." (3/6/2017)

Who are some of McKesson's key competitors?

Who are McKesson's key executives?

McKesson's management team includes the folowing people:

  • John Harvey Hammergren, Chairman of the Board, President, Chief Executive Officer (Age 58)
  • Britt Vitalone, Chief Financial Officer, Executive Vice President (Age 48)
  • Kathleen D. McElligott, Executive Vice President, Chief Technology Officer, Chief Information Officer (Age 61)
  • Lori Ann Schechter, Executive Vice President, Chief Compliance Officer, General Counsel (Age 55)
  • Jorge L. Figueredo, Executive Vice President - Human Resources (Age 56)
  • Paul Coleman Julian, Executive Vice President, Group President (Age 61)
  • Bansi Nagji, Executive Vice President - Corporate Strategy and Business Development (Age 52)
  • Edward A. Mueller, Lead Independent Director (Age 70)
  • Andrew D. Bryant, Independent Director (Age 67)
  • N. Anthony Coles Jr., M.D., Independent Director (Age 57)

Who owns McKesson stock?

McKesson's stock is owned by many different of institutional and retail investors. Top institutional investors include BlackRock Inc. (7.67%), Vulcan Value Partners LLC (1.75%), Bank of New York Mellon Corp (1.31%), Pzena Investment Management LLC (1.26%), Alliancebernstein L.P. (1.19%) and Geode Capital Management LLC (1.10%). Company insiders that own McKesson stock include Erin M Lampert, James A Beer, John H Hammergren, Lori A Schechter, M Christine Jacobs, Marie L/Ca Knowles, Nigel A Rees, Patrick Blake, Susan R Salka and Wayne A Budd. View Institutional Ownership Trends for McKesson.

Who sold McKesson stock? Who is selling McKesson stock?

McKesson's stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Mackenzie Financial Corp, Bank of Montreal Can, Two Sigma Advisers LP, Gotham Asset Management LLC, Caisse DE Depot ET Placement DU Quebec, The Manufacturers Life Insurance Company and Wells Fargo & Company MN. Company insiders that have sold McKesson company stock in the last year include Erin M Lampert, John H Hammergren, M Christine Jacobs and Marie L/Ca Knowles. View Insider Buying and Selling for McKesson.

Who bought McKesson stock? Who is buying McKesson stock?

McKesson's stock was bought by a variety of institutional investors in the last quarter, including Boston Partners, Kiltearn Partners LLP, Amundi Pioneer Asset Management Inc., Schroder Investment Management Group, Vulcan Value Partners LLC, Robeco Institutional Asset Management B.V., Bank of New York Mellon Corp and SG Americas Securities LLC. Company insiders that have bought McKesson stock in the last two years include Lori A Schechter and Susan R Salka. View Insider Buying and Selling for McKesson.

How do I buy McKesson stock?

Shares of McKesson can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is McKesson's stock price today?

One share of McKesson stock can currently be purchased for approximately $150.50.

How big of a company is McKesson?

McKesson has a market capitalization of $31.38 billion and generates $198.53 billion in revenue each year. The company earns $5.07 billion in net income (profit) each year or $20.80 on an earnings per share basis. McKesson employs 78,000 workers across the globe.

How can I contact McKesson?

McKesson's mailing address is 1 Post St, SAN FRANCISCO, CA 94104-5203, United States. The company can be reached via phone at +1-415-9838300 or via email at [email protected]

MarketBeat Community Rating for McKesson (MCK)

Community Ranking:  3.3 out of 5 (star star star)
Outperform Votes:  689 (Vote Outperform)
Underperform Votes:  342 (Vote Underperform)
Total Votes:  1,031
MarketBeat's community ratings are surveys of what our community members think about McKesson and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

McKesson (NYSE:MCK) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyHold
Consensus Rating Score: 2.572.532.502.38
Ratings Breakdown: 1 Sell Rating(s)
4 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
5 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
5 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
8 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $178.57$175.67$173.21$169.50
Price Target Upside: 7.40% upside1.64% upside23.41% upside4.29% upside

McKesson (NYSE:MCK) Consensus Price Target History

Price Target History for McKesson (NYSE:MCK)

McKesson (NYSE:MCK) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/2/2018Credit Suisse GroupReiterated RatingSell$130.00HighView Rating Details
2/2/2018MizuhoLower Price TargetNeutral -> Neutral$186.00 -> $179.00HighView Rating Details
1/24/2018Jefferies GroupUpgradeHold -> Buy$205.00HighView Rating Details
1/23/2018Needham & Company LLCBoost Price TargetBuy -> Buy$173.00 -> $180.00MediumView Rating Details
1/17/2018Robert W. BairdReiterated RatingBuy$200.00LowView Rating Details
1/4/2018Evercore ISIInitiated CoverageOutperform -> Outperform$179.00LowView Rating Details
12/4/2017Deutsche BankInitiated CoverageBuy$175.00HighView Rating Details
10/27/2017Royal Bank of CanadaReiterated RatingHold$170.00N/AView Rating Details
10/10/2017CowenUpgradeMarket Perform -> Outperform$176.00 -> $189.00N/AView Rating Details
9/14/2017Morgan StanleyDowngradeOverweight -> Equal Weight$184.00 -> $172.00HighView Rating Details
6/29/2017Leerink SwannBoost Price TargetMarket Perform$170.00MediumView Rating Details
6/4/2017BarclaysSet Price TargetBuy$187.00LowView Rating Details
5/23/2017JPMorgan Chase & Co.UpgradeNeutral -> Overweight$189.00MediumView Rating Details
3/6/2017CitigroupBoost Price TargetBuy$169.00 -> $175.00N/AView Rating Details
1/18/2017Avondale PartnersUpgradeMarket Perform -> Outperform$157.00 -> $193.00N/AView Rating Details
11/11/2016Standpoint ResearchDowngradeBuy -> HoldN/AView Rating Details
9/19/2016ArgusReiterated RatingHoldN/AView Rating Details
9/16/2016Goldman Sachs GroupDowngradeBuy -> Neutral$210.00 -> $189.00N/AView Rating Details
6/30/2016Bank of AmericaReiterated RatingHoldN/AView Rating Details
6/29/2016FBR & CoReiterated RatingBuy$210.00N/AView Rating Details
6/1/2016Raymond James FinancialDowngradeStrong-Buy -> OutperformN/AView Rating Details
(Data available from 2/17/2016 forward)


McKesson (NYSE:MCK) Earnings History and Estimates Chart

Earnings by Quarter for McKesson (NYSE:MCK)

McKesson (NYSE MCK) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/16/2018$3.56N/AView Earnings Details
2/1/2018Q3 2018$2.92$3.41$51.98 billion$53.62 billionViewN/AView Earnings Details
10/26/2017Q2 2018$2.78$3.28$51.69 billion$52.06 billionViewN/AView Earnings Details
7/27/2017Q1 2018$2.81$2.46$51.22 billion$51.05 billionViewN/AView Earnings Details
5/18/2017Q4 17$3.04$3.39$49.48 billion$48.71 billionViewN/AView Earnings Details
1/25/2017Q317$2.95$3.03$50.71 billion$50.13 billionViewN/AView Earnings Details
10/27/2016Q217$3.05$2.94$24.16 billion$49.96 billionViewListenView Earnings Details
7/27/2016Q117$3.33$3.50$50.32 billion$49.73 billionViewListenView Earnings Details
5/4/2016Q416$3.14$2.44$46.83 billion$46.68 billionViewN/AView Earnings Details
1/27/2016Q316$3.13$3.18$48.97 billion$47.90 billionViewListenView Earnings Details
10/29/2015Q216$2.99$3.31$47.85 billion$48.60 billionViewListenView Earnings Details
7/29/2015Q116$2.89$3.14$46.02 billion$47.50 billionViewListenView Earnings Details
5/12/2015Q415$2.75$2.94$45.00 billion$44.93 billionViewListenView Earnings Details
2/5/2015Q315$2.61$2.89$44.81 billion$47.01 billionViewN/AView Earnings Details
10/28/2014Q215$2.73$2.79$42.99 billion$44.76 billionViewN/AView Earnings Details
7/31/2014Q115$2.34$2.49$40.65 billion$44.06 billionViewN/AView Earnings Details
5/12/2014Q414$2.40$2.55$35.89 billion$38.14 billionViewN/AView Earnings Details
1/31/2014Q314$1.85$1.45$38.57 billion$34.30 billionViewN/AView Earnings Details
10/24/2013Q214$2.03$2.27$32.16 billion$33.00 billionViewListenView Earnings Details
7/25/2013Q1 2014$1.71$2.07$32.60 billion$32.20 billionViewListenView Earnings Details
5/7/2013Q4 2013$2.30$1.45$32.01 billion$30.62 billionViewListenView Earnings Details
1/31/2013Q3 2013$1.62$1.41$30.81 billion$31.19 billionViewListenView Earnings Details
10/25/2012$1.78$1.92ViewN/AView Earnings Details
7/26/2012$1.48$1.55ViewN/AView Earnings Details
4/30/2012$2.04$2.09ViewN/AView Earnings Details
1/30/2012$1.38$1.40ViewN/AView Earnings Details
10/25/2011$1.38$1.63ViewN/AView Earnings Details
7/28/2011$1.10$1.27ViewN/AView Earnings Details
5/3/2011$1.60$1.66ViewN/AView Earnings Details
1/31/2011$1.12$1.12ViewN/AView Earnings Details
10/26/2010Q2 2011$1.09$1.03ViewN/AView Earnings Details
7/30/2010Q1 2011$1.07$1.10ViewN/AView Earnings Details
5/3/2010Q4 2010$1.29$1.27ViewN/AView Earnings Details
1/26/2010Q3 2010$1.19$1.19ViewN/AView Earnings Details
10/27/2009Q2 2010$1.01$1.07ViewN/AView Earnings Details
7/28/2009Q1 2010$0.86$1.06ViewN/AView Earnings Details
5/4/2009Q4 2009$1.15$1.23ViewN/AView Earnings Details
1/26/2009Q3 2009$0.86$1.05ViewN/AView Earnings Details
10/28/2008Q2 2009$1.02$1.17ViewN/AView Earnings Details
7/23/2008Q1 2009$0.80$0.83ViewN/AView Earnings Details
5/5/2008Q4 2008$1.00$1.05ViewN/AView Earnings Details
1/31/2008Q3 2008$0.80$0.79ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


McKesson (NYSE:MCK) Earnings Estimates

2018 EPS Consensus Estimate: $12.24
2019 EPS Consensus Estimate: $12.89
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20182$2.85$2.88$2.87
Q2 20182$2.80$2.82$2.81
Q3 20182$2.90$2.91$2.91
Q4 20182$3.54$3.78$3.66
Q1 20191$2.82$2.82$2.82
Q2 20191$3.01$3.01$3.01
Q3 20191$3.24$3.24$3.24
Q4 20191$3.82$3.82$3.82
(Earnings estimates data provided by Zacks Investment Research)


McKesson (NYSE:MCK) Dividend Information

Next Dividend:4/2/2018
Annual Dividend:$1.36
Dividend Yield:0.90%
Dividend Growth:7.10% (3 Year Average)
Payout Ratio:6.54% (Trailing 12 Months of Earnings)
10.70% (Based on This Year's Estimates)
10.08% (Based on Next Year's Estimates)
Track Record:5 Years of Consecutive Dividend Growth
Frequency:Quarterly Dividend
Dividend Payments by Quarter for McKesson (NYSE:MCK)

McKesson (NYSE:MCK) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

McKesson (NYSE MCK) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 1.20%
Institutional Ownership Percentage: 86.63%
Insider Trades by Quarter for McKesson (NYSE:MCK)
Institutional Ownership by Quarter for McKesson (NYSE:MCK)

McKesson (NYSE MCK) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/14/2017John H. HammergrenChairmanSell65,000$160.00$10,400,000.00View SEC Filing  
9/29/2017John H HammergrenCEOSell99,000$153.89$15,235,110.00165,000View SEC Filing  
9/28/2017John H HammergrenCEOSell100,000$153.51$15,351,000.00165,000View SEC Filing  
9/27/2017John H HammergrenCEOSell100,000$155.30$15,530,000.00165,000View SEC Filing  
9/26/2017John H HammergrenCEOSell100,000$154.81$15,481,000.00165,000View SEC Filing  
9/25/2017John H HammergrenCEOSell100,000$154.15$15,415,000.00165,000View SEC Filing  
9/22/2017John H. HammergrenChairmanSell225,000$151.67$34,125,750.00View SEC Filing  
9/22/2017John H. HammergrenCEOSell100,000$153.53$15,353,000.00View SEC Filing  
9/20/2017John H. HammergrenCEOSell125,000$150.18$18,772,500.00View SEC Filing  
9/7/2017Erin M. LampertSVPSell900$155.65$140,085.00View SEC Filing  
8/21/2017M Christine JacobsDirectorSell1,083$145.43$157,500.69View SEC Filing  
7/31/2017Marie L/Ca KnowlesDirectorSell1,083$162.55$176,041.65View SEC Filing  
6/1/2017John H HammergrenChairmanSell38,619$163.76$6,324,247.4419,309View SEC Filing  
5/31/2017Erin M LampertSVPSell809$160.66$129,973.9459View SEC Filing  
5/30/2017Erin M LampertSVPSell404$160.53$64,854.122,003View SEC Filing  
5/30/2017John H HammergrenChairmanSell19,316$162.31$3,135,179.9696,644View SEC Filing  
3/29/2017John H HammergrenChairmanSell100,500$150.44$15,119,220.0022,390View SEC Filing  
3/2/2017John H HammergrenChairmanSell100,500$150.49$15,124,245.0057,900View SEC Filing  
12/5/2016Wayne A. BuddDirectorSell723$145.77$105,391.71View SEC Filing  
11/30/2016Lori A SchechterEVPBuy692$144.52$100,007.84View SEC Filing  
11/2/2016Susan R SalkaDirectorBuy1,000$136.35$136,350.00View SEC Filing  
10/31/2016Erin M LampertSVPSell921$123.99$114,194.791,765View SEC Filing  
10/3/2016Erin M. LampertSVPSell1,739$165.94$288,569.66View SEC Filing  
9/12/2016John H HammergrenChairmanSell100,500$180.77$18,167,385.00100,500View SEC Filing  
9/12/2016Wayne A BuddDirectorSell2,309$179.70$414,927.30723View SEC Filing  
9/6/2016John H HammergrenChairmanSell100,500$184.22$18,514,110.00100,500View SEC Filing  
8/22/2016M Christine JacobsDirectorSell915$193.78$177,308.70View SEC Filing  
8/1/2016Marie L/Ca KnowlesDirectorSell915$192.73$176,347.95View SEC Filing  
7/14/2016James A BeerCFOSell5,500$199.00$1,094,500.0012,412View SEC Filing  
5/25/2016John H HammergrenCEOSell37,420$182.87$6,842,995.4018,711View SEC Filing  
5/25/2016Patrick BlakeEVPSell6,322$182.87$1,156,104.145,328View SEC Filing  
5/24/2016John H HammergrenCEOSell18,709$182.06$3,406,160.5418,711View SEC Filing  
5/24/2016Lori A SchechterEVPSell107$182.06$19,480.426,259View SEC Filing  
5/23/2016John H HammergrenCEOSell18,718$179.33$3,356,698.9494,000View SEC Filing  
5/23/2016Patrick BlakeEVPSell3,162$179.33$567,041.4620,167View SEC Filing  
5/10/2016John H HammergrenCEOSell101,833$170.71$17,383,911.43101,833View SEC Filing  
4/25/2016John H HammergrenCEOSell101,833$176.81$18,005,092.73101,833View SEC Filing  
4/4/2016John H HammergrenCEOSell45,300$159.00$7,202,700.0045,300View SEC Filing  
3/15/2016Nigel A ReesSVPSell6,000$157.59$945,540.0011,000View SEC Filing  
2/2/2016Susan R SalkaDirectorBuy1,000$156.21$156,210.00View SEC Filing  
2/1/2016Lori A. SchechterEVPSell2,476$159.73$395,491.48View SEC Filing  
1/4/2016John H. HammergrenCEOSell101,833$194.11$19,766,803.63View SEC Filing  
12/1/2015John H. HammergrenCEOSell101,833$190.06$19,354,379.98View SEC Filing  
11/24/2015John H. HammergrenCEOSell56,533$190.01$10,741,835.33View SEC Filing  
10/12/2015John H. HammergrenCEOSell101,835$190.51$19,400,585.85View SEC Filing  
8/13/2015Paul C JulianEVPSell55,666$214.54$11,942,583.64View SEC Filing  
7/15/2015Paul C JulianEVPSell27,833$234.04$6,514,035.32View SEC Filing  
7/14/2015Paul C JulianEVPSell27,833$232.86$6,481,192.38View SEC Filing  
6/17/2015Paul C JulianEVPSell55,668$234.06$13,029,652.08View SEC Filing  
5/28/2015John H HammergrenCEOSell60,000$238.53$14,311,800.00View SEC Filing  
5/28/2015Lori A SchechterEVPSell1,468$238.22$349,706.96View SEC Filing  
5/26/2015John H HammergrenCEOSell30,062$238.97$7,183,916.14View SEC Filing  
5/26/2015Paul C JulianEVPSell15,289$238.97$3,653,612.33View SEC Filing  
5/22/2015Jorge FigueredoEVPSell20,775$240.11$4,988,285.25View SEC Filing  
5/15/2015Jorge FigueredoEVPSell8,525$240.00$2,046,000.00View SEC Filing  
2/17/2015Randall N SprattEVPSell44,523$225.00$10,017,675.00View SEC Filing  
2/12/2015Randall N SprattEVPSell7,477$225.00$1,682,325.00View SEC Filing  
2/10/2015Alton F Irby IIIDirectorSell5,000$220.76$1,103,800.00View SEC Filing  
2/10/2015Nigel A ReesMajor ShareholderSell9,000$220.42$1,983,780.00View SEC Filing  
1/28/2015John H HammergrenCEOSell64,521$219.52$14,163,649.92View SEC Filing  
1/26/2015Brian Scott TylerEVPSell5,431$216.62$1,176,463.22View SEC Filing  
1/26/2015John H HammergrenCEOSell35,479$219.07$7,772,384.53View SEC Filing  
1/7/2015John H HammergrenCEOSell77,100$214.00$16,499,400.00View SEC Filing  
12/8/2014John H HammergrenCEOSell12,200$214.01$2,610,922.00View SEC Filing  
11/28/2014Patrick BlakeEVPSell19,000$210.00$3,990,000.00View SEC Filing  
11/24/2014John H HammergrenCEOSell100,000$209.25$20,925,000.00View SEC Filing  
11/12/2014Paul C JulianEVPSell74,666$202.51$15,120,611.66View SEC Filing  
10/31/2014Patrick BlakeEVPSell38,000$204.68$7,777,840.00View SEC Filing  
10/8/2014Paul C JulianEVPSell74,667$195.86$14,624,278.62View SEC Filing  
10/7/2014John H HammergrenCEOSell100,000$197.28$19,728,000.00View SEC Filing  
9/10/2014Paul C JulianEVPSell74,667$196.76$14,691,478.92View SEC Filing  
8/29/2014Jorge FigueredoEVPSell24,500$195.00$4,777,500.00View SEC Filing  
8/8/2014M Christine JacobsDirectorSell2,619$189.88$497,295.72View SEC Filing  
8/5/2014Marie L/Ca KnowlesDirectorSell785$192.10$150,798.50View SEC Filing  
6/2/2014Patrick BlakeEVPSell15,000$190.00$2,850,000.00View SEC Filing  
5/29/2014Paul C JulianEVPSell21,057$186.89$3,935,342.73View SEC Filing  
5/28/2014Alton F Irby IIIDirectorSell4,000$182.73$730,920.00View SEC Filing  
5/28/2014John H HammergrenCEOSell125,596$183.31$23,023,002.76View SEC Filing  
5/28/2014Jorge FigueredoEVPSell20,542$183.30$3,765,348.60View SEC Filing  
5/27/2014Brian Scott TylerEVPSell3,916$183.30$717,802.80View SEC Filing  
5/22/2014Brian Scott TylerEVPSell8,250$184.17$1,519,402.505View SEC Filing  
3/21/2014Jorge FigueredoEVPSell23,684$185.81$4,400,724.04View SEC Filing  
3/10/2014Patrick BlakeEVPSell38,750$180.36$6,988,950.001,827View SEC Filing  
2/4/2014Brian Scott TylerEVPSell6,250$169.68$1,060,500.005View SEC Filing  
1/22/2014Alton Irby IIIDirectorSell1,300$167.98$218,374.0025,599View SEC Filing  
11/1/2013Nigel A ReesCFOSell7,000$158.72$1,111,040.00View SEC Filing  
10/29/2013Brian Scott TylerEVPSell8,250$153.44$1,265,880.00View SEC Filing  
10/11/2013Brian Scott TylerEVPSell9,000$138.51$1,246,590.005View SEC Filing  
10/9/2013Paul JulianEVPSell84,000$134.04$11,259,360.0057View SEC Filing  
10/8/2013Brian Scott TylerEVPSell9,000$138.00$1,242,000.005View SEC Filing  
9/11/2013Paul C JulianEVPSell84,000$126.20$10,600,800.00View SEC Filing  
8/7/2013Paul JulianEVPSell84,000$123.29$10,356,360.0057View SEC Filing  
8/6/2013Marie L/Ca KnowlesDirectorSell1,223$123.54$151,089.42View SEC Filing  
7/30/2013Brian Scott TylerEVPSell6,250$123.94$774,625.00View SEC Filing  
6/19/2013Paul C JulianEVPSell84,750$114.89$9,736,927.50View SEC Filing  
6/14/2013David M LawrenceDirectorSell7,500$114.28$857,100.00View SEC Filing  
6/14/2013Jorge FigueredoEVPSell6,250$115.00$718,750.00View SEC Filing  
6/10/2013Jorge FigueredoEVPSell10,000$115.00$1,150,000.00View SEC Filing  
6/4/2013Jorge FigueredoEVPSell22,500$113.63$2,556,675.00View SEC Filing  
5/30/2013Laureen SeegerEVPSell57,750$114.89$6,634,897.50View SEC Filing  
5/29/2013John H HammergrenCEOSell230,484$115.21$26,554,061.64View SEC Filing  
5/29/2013Randall N SprattEVPSell32,226$115.21$3,712,757.46View SEC Filing  
5/28/2013Brian Scott TylerEVPSell6,023$116.33$700,655.59View SEC Filing  
5/28/2013Jeffrey C CampbellCFOSell73,102$116.33$8,503,955.66View SEC Filing  
5/24/2013Laureen SeegerEVPSell17,250$116.50$2,009,625.00View SEC Filing  
5/22/2013Laureen SeegerEVPSell17,250$118.13$2,037,742.50View SEC Filing  
5/20/2013Brian Scott TylerEVPSell5,000$117.81$589,050.00View SEC Filing  
5/15/2013Nigel A ReesVPSell8,000$116.00$928,000.00View SEC Filing  
5/10/2013Brian Scott TylerEVPSell6,250$115.59$722,437.50View SEC Filing  
5/10/2013John H HammergrenCEOSell75,000$115.30$8,647,500.00View SEC Filing  
1/18/2013Jorge FigueredoEVPSell2,500$103.22$258,050.00View SEC Filing  
1/17/2013Laureen SeegerEVPSell17,250$103.00$1,776,750.00View SEC Filing  
9/4/2012Paul C JulianEVPSell36,250$87.02$3,154,475.00View SEC Filing  
(Data available from 1/1/2013 forward)


McKesson (NYSE MCK) News Headlines

McKesson (MCK) Cut to "Hold" at ValuEngineMcKesson (MCK) Cut to "Hold" at ValuEngine - February 17 at 6:34 PM
Alphabet-backed Flatiron Health is being acquired by Roche - CNBCAlphabet-backed Flatiron Health is being acquired by Roche - CNBC - February 17 at 8:00 AM
McKesson: What Does The Future Hold?McKesson: What Does The Future Hold? - February 15 at 5:34 PM
Activist DeRay Mckesson will publish his first book in SeptemberActivist DeRay Mckesson will publish his first book in September - February 15 at 5:34 PM
How Amazon could lose its health-care bid while drug distributor stocks winHow Amazon could lose its health-care bid while drug distributor stocks win - February 15 at 5:34 PM
McKesson (MCK) Lowered to "Hold" at Zacks Investment ResearchMcKesson (MCK) Lowered to "Hold" at Zacks Investment Research - February 15 at 2:44 PM
McKesson Co. (MCK) Given Average Rating of "Hold" by BrokeragesMcKesson Co. (MCK) Given Average Rating of "Hold" by Brokerages - February 14 at 3:42 PM
McKesson (MCK) Lifted to Buy at Zacks Investment ResearchMcKesson (MCK) Lifted to Buy at Zacks Investment Research - February 14 at 12:24 PM
Hospital supplier shares dive as Amazon reportedly ramps up medical supply businessHospital supplier shares dive as Amazon reportedly ramps up medical supply business - February 13 at 3:29 PM
BRIEF-McKesson Corp Files Preliminary Prospectus Supplement Related To A Potential Two-Part Note OfferingBRIEF-McKesson Corp Files Preliminary Prospectus Supplement Related To A Potential Two-Part Note Offering - February 9 at 3:38 PM
How Valeant Pharmaceuticals Has Fared in 2018How Valeant Pharmaceuticals Has Fared in 2018 - February 9 at 3:38 PM
McKesson Pharmacy Systems and Creative Pharmacist Collaborate to Enhance Clinical Programs for Community ... - Business Wire (press release)McKesson Pharmacy Systems and Creative Pharmacist Collaborate to Enhance Clinical Programs for Community ... - Business Wire (press release) - February 9 at 7:25 AM
BRIEF-Mckesson Files Preliminary Prospectus Supplement Related To Potential Offering Of NotesBRIEF-Mckesson Files Preliminary Prospectus Supplement Related To Potential Offering Of Notes - February 8 at 3:29 PM
McKesson Corporation -- Moodys assigns Baa2 to McKessons new Euro and US notesMcKesson Corporation -- Moody's assigns Baa2 to McKesson's new Euro and US notes - February 8 at 7:13 AM
McKesson Corporation Announces Offer to Purchase Up to $1,100,000,000 Combined Purchase Price of Outstanding 6.000% Notes due 2041, 7.650% Debentures due 2027, 4.883% Notes due 2044, 4.750% Notes due 2021 and 7.500% Notes due 2019McKesson Corporation Announces Offer to Purchase Up to $1,100,000,000 Combined Purchase Price of Outstanding 6.000% Notes due 2041, 7.650% Debentures due 2027, 4.883% Notes due 2044, 4.750% Notes due 2021 and 7.500% Notes due 2019 - February 7 at 4:28 AM
AmerisourceBergen sees $60 mln hit from troubled Memphis plantAmerisourceBergen sees $60 mln hit from troubled Memphis plant - February 6 at 3:29 PM
McKesson Medical-Surgical to Offer New Sysmex Device That Provides Blood Test Results at Point of Care in MinutesMcKesson Medical-Surgical to Offer New Sysmex Device That Provides Blood Test Results at Point of Care in Minutes - February 5 at 3:28 PM
Zacks Investment Research Downgrades McKesson (MCK) to HoldZacks Investment Research Downgrades McKesson (MCK) to Hold - February 5 at 3:18 PM
Q1 2019 Earnings Estimate for McKesson Co. Issued By Leerink Swann (MCK)Q1 2019 Earnings Estimate for McKesson Co. Issued By Leerink Swann (MCK) - February 5 at 7:40 AM
McKesson Co. to Post FY2018 Earnings of $12.70 Per Share, Jefferies Group Forecasts (MCK)McKesson Co. to Post FY2018 Earnings of $12.70 Per Share, Jefferies Group Forecasts (MCK) - February 5 at 5:28 AM
McKesson (MCK) Q3 2018 Earnings Conference Call TranscriptMcKesson (MCK) Q3 2018 Earnings Conference Call Transcript - February 4 at 5:43 PM
Mizuho Cuts McKesson (MCK) Price Target to $179.00Mizuho Cuts McKesson (MCK) Price Target to $179.00 - February 3 at 6:00 PM
McKesson (MCK) Beats on Earnings and Sales in Q3McKesson (MCK) Beats on Earnings and Sales in Q3 - February 2 at 3:31 PM
UPDATE 1-Drug distributor McKessons quarterly profit beats estimatesUPDATE 1-Drug distributor McKesson's quarterly profit beats estimates - February 2 at 3:31 PM
McKesson beats Street 3Q forecastsMcKesson beats Street 3Q forecasts - February 2 at 3:31 PM
McKesson (MCK) Stock Rating Reaffirmed by Credit Suisse GroupMcKesson (MCK) Stock Rating Reaffirmed by Credit Suisse Group - February 2 at 12:34 PM
McKesson (MCK) Upgraded at Zacks Investment ResearchMcKesson (MCK) Upgraded at Zacks Investment Research - February 2 at 10:28 AM
McKesson says drug prices competitive but not volatile like 2017McKesson says drug prices competitive but not volatile like 2017 - February 1 at 3:29 PM
McKesson (MCK) Beats on Q3 Earnings & Revenues, Ups '18 ViewMcKesson (MCK) Beats on Q3 Earnings & Revenues, Ups '18 View - February 1 at 3:29 PM
McKesson Continues Its TransformationMcKesson Continues Its Transformation - February 1 at 11:09 AM
McKesson (MCK) Announces Quarterly  Earnings ResultsMcKesson (MCK) Announces Quarterly Earnings Results - February 1 at 10:02 AM
McKesson (MCK) Updates FY18 Earnings GuidanceMcKesson (MCK) Updates FY18 Earnings Guidance - February 1 at 9:31 AM
McKesson Co. (MCK) to Issue Quarterly Dividend of $0.34McKesson Co. (MCK) to Issue Quarterly Dividend of $0.34 - February 1 at 9:08 AM
Drug distributor McKesson posts 42.6 pct rise in quarterly profitDrug distributor McKesson posts 42.6 pct rise in quarterly profit - February 1 at 7:31 AM
McKesson Reports Fiscal 2018 Third-Quarter ResultsMcKesson Reports Fiscal 2018 Third-Quarter Results - February 1 at 7:31 AM
McKesson shares rise after Q3 profit, revenue beats; upbeat outlookMcKesson shares rise after Q3 profit, revenue beats; upbeat outlook - February 1 at 7:31 AM
McKesson Co. (MCK) Expected to Announce Quarterly Sales of $51.98 BillionMcKesson Co. (MCK) Expected to Announce Quarterly Sales of $51.98 Billion - February 1 at 3:00 AM
Colorado county sues drug companies over opioid crisisColorado county sues drug companies over opioid crisis - January 30 at 3:29 PM
McKesson (MCK) Lifted to "Buy" at Jefferies GroupMcKesson (MCK) Lifted to "Buy" at Jefferies Group - January 28 at 6:36 PM
Value Screeners Identify Good Opportunities for 2018Value Screeners Identify Good Opportunities for 2018 - January 27 at 7:16 AM
Mckesson (MCK) to Report Q3 Earnings: A Beat in the Cards?Mckesson (MCK) to Report Q3 Earnings: A Beat in the Cards? - January 26 at 3:30 PM
Jefferies Group Research Analysts Boost Earnings Estimates for McKesson Co. (MCK)Jefferies Group Research Analysts Boost Earnings Estimates for McKesson Co. (MCK) - January 26 at 10:22 AM
McKesson Co. (MCK) to Post FY2018 Earnings of $12.23 Per Share, Jefferies Group ForecastsMcKesson Co. (MCK) to Post FY2018 Earnings of $12.23 Per Share, Jefferies Group Forecasts - January 25 at 12:26 PM
[$$] Landmark Health Explores Possible Sale[$$] Landmark Health Explores Possible Sale - January 25 at 7:19 AM
NYC Joins Cities, Counties and States In Bringing Opioid LawsuitNYC Joins Cities, Counties and States In Bringing Opioid Lawsuit - January 25 at 7:19 AM
McKesson (MCK) to Release Quarterly Earnings on ThursdayMcKesson (MCK) to Release Quarterly Earnings on Thursday - January 25 at 1:44 AM
McKesson (MCK) Given a $186.00 Price Target at MizuhoMcKesson (MCK) Given a $186.00 Price Target at Mizuho - January 24 at 11:18 PM
New York City sues drug companies over opioid epidemicNew York City sues drug companies over opioid epidemic - January 23 at 2:02 PM
McKesson Co. (MCK) Receives Average Recommendation of "Hold" from AnalystsMcKesson Co. (MCK) Receives Average Recommendation of "Hold" from Analysts - January 20 at 3:52 PM
Mckesson Earns Relative Strength Rating UpgradeMckesson Earns Relative Strength Rating Upgrade - January 18 at 10:55 AM

SEC Filings

McKesson (NYSE:MCK) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


McKesson (NYSE:MCK) Income Statement, Balance Sheet and Cash Flow Statement


McKesson (NYSE MCK) Stock Chart for Saturday, February, 17, 2018

Loading chart…

This page was last updated on 2/17/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.